https://www.avient.com/sites/default/files/2023-09/OnColor Laundry Detergent Case Study Snapshot.pdf
L E A D I N G H O U S E H O L D G O O D S M A N U FA C T U R E R L A U N D R Y D E T E R G E N T B O T T L E • Increase post-consumer recycled (PCR) content to help meet state minimum standards • Improve color consistency to achieve global brand harmony and enhance on-shelf presence • Raised PCR level to 40% of the bottle weight, meeting sustainability goals and minimum PCR content regulations • Reduced thickness of outer bottle layer by 30% while increasing opacity, and removed colorant from middle layer • Delivered improved color consistency • Offered cost savings with a concentrated solution • Deployed on-site scale-up support at all converter locations OnColor™ Polymer Colorants – Super Concentrated Formulation KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-09/avnt-q2-2021-earnings-presentation.pdf
D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of 2021年7月28日 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of 2021年7月28日 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 A vi e n t K W R P P G A V Y F U L R P M G C P F M C U N V R C E IF F A S H E C L B N R E M N H X L H U N K R A S C L A L B (6) Source: Peer data per Bloomberg market data as of 2021年7月28日 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 25 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 18.5 15.1 15.1 14.0 11.0 10.4 29.5 28.2 23.9 18.7 12.4 12.2 11.1 9.3 9.2 9.2 7.6 7.6 6.0 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L IF F F M C B N R A S H S C L E M N U N V R K R A C E H U N Median: 11.1xMedian: 14.6x S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/news/archives?page=45
PolyOne Launches First-Ever TPE with Blue Jean Stain Resistance for Phone Cases CLEVELAND – 2018年5月1日 – PolyOne will invite NPE show attendees next week to “Explore the Possibilities” in a meeting center that showcases h
https://www.avient.com/sites/default/files/2020-09/stat-tech-tri-fold-processing-guide.pdf
Base Resin PC PC/PSU PES PEI PP ABS PEEK PA Barrel Temperatures* °F (°C) Rear Zone 530–560 (277–293) 550–575 (288–302) 660–700 (349–371) 675–725 (357–385) 390–420 (199–216) 425–460 (219–238) 680–730 (360–388) 430–500 (221–260) Center Zone 515–560 (269–288) 540–565 (282–296) 650–690 (343–366) 655–710 (352–377) 380–405 (193–207) 415–450 (213–232) 670–710 (354–377) 420–490 (216–254) Front Zone 510–525 (266–274) 530–555 (277–291) 640–680 (338–360) 655–700 (346–371) 370–395 (188–202) 405–440 (207–227) 650–690 (343–366) 410–480 (210–249) Nozzle 520–535 (271–280) 540–565 (282–296) 650–690 (343–366) 665–710 (352–377) 380–400 (193–204) 415–450 (213–232) 660–700 (349–371) 420–490 (216–254) Melt Temperature 525–560 (274–293) 530–580 (277–304) 650–700 (343–371) 660–730 (349–388) 375–395 (191–202) 410–460 (210–238) 650–730 (343–388) 420–500 (216–260) Mold Temperature 175–250 (80–121) 160–220 (71–104) 280–350 (138–177) 275–350 (135–177) 100–135 (38–57) 150–180 (66–82) 300–425 (149–219) 160–230 (71–110) Pack & Hold Pressure 50%–75% of Injection Pressure Injection Velocity in/s 0.5–2.0 Back Pressure psi 50 Screw Speed rpm 40–70 40–70 40–70 40–70 40–70 40–70 40–70 40–70** Drying Parameters °F (°C) 6 hrs @ 250 (121) 4 hrs @ 250 (121) 4 hrs @ 275 (135) 4 hrs @ 250 (121) 3 hrs @ 300 (150) 2 hrs @ 200 (93) 3 hrs @ 275 (135) 4 hrs @ 180 (82) Cushion in 0.125–0.250 Screw Compression Ratio 2.0:1–2.5:1 2.0:1–2.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 Nozzle Type General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose Reverse Taper Clamp Pressure 5–6 Tons/in2 * A reverse temperature profile is important to obtain optimum conductive properties. Only naturally balanced runner systems (“H” pattern) are recommended
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
W H O W E A R E – V I S I O N , S T R AT E G Y, C U LT U R E 3 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of 2021年11月8日 86 93 85 83 79 77 75 89 85 83 81 79 79 78 77 74 25 A vi e n t K W R P P G A V Y F U L R P M G C P F M C U N V R C E B N R H X L A S H E C L E M N H U N S C L A L B (10) Source: Peer data per Bloomberg market data as of 2021年11月8日 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below many of our specialty formulator peers. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
Microsoft PowerPoint - Avient Q4 Earnings and 2021 Outlook PRINT AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 0 R E S U L T S A N D 2 0 2 1 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 9 , 2 0 2 1 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of 2021年2月5日 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 A vi e n t P P G K W R R P M F U L A V Y G C P IF F F M C U N V R H X L E M N B N R E C L C E A S H F O E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of 2021年2月5日 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $510M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi e n t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/sites/default/files/2021-02/mevopur-needle-one-pager-case-study.pdf
H Y P O D E R M I C N E E D L E M A N U FAC T U R E R N E E D L E H U B , C O V E R A N D S H I E L D • Compliance to ISO 6009 color coding for single use hypodermic needle • Biocompatibility of all component materials • Good mechanical and visual properties after sterilization (e.g.
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-technical-bulletin-sept-2020.pdf
BENEFITS OF VERSAFLEX PF FOR SURFACE PROTECTIVE FILMS: • Customizable tack • Single-step manufacturing process (co- extrusion) • Low volatile organic compound (VOC) emissions during manufacturing • Eliminates secondary coating and drying operations • Eliminates hazardous liquid chemicals compared to solvent systems • Reduces converting costs versus coating • Reduces energy consumption MARKETS AND APPLICATIONS Versaflex PF formulations, customizable based on desired level of tack, are co-extruded with protective films to provide just the right amount of protection during the fabrication, assembly, shipment, storage and installation of finished goods in many industries and end-use applications including: • Optical films and display panels for consumer electronics • Home appliances • Construction and building materials • Furniture and cabinetry • Automotive and other transportation 100/0 90/10 80/20 70/30 60/40 40/60 30/70 20/80 10/90 0/100 0.9 1.1 2.0 2.4 2.8 3.7 3.8 4.9 0 1 2 3 4 5 6 7 8 6.5 1.6 Versaflex PF MD6727 Versaflex PF MD6748 Versaflex PF MD6700 Versaflex PF MD6666 Versaflex PF 9512 Versaflex PF MD6649 Versaflex PF MD6741 0 2 4 6 8 10 12 % of MD6741/MD6700 Degree of tack can be customized for substrate surfaces. TAILORING TACK BY BLENDING VERSAFLEX PF Film Thickness: 39 micron LDPE/13 micron Versaflex PF F = Final tack after 7 days @ 25° C i = Initial tack after 20 mins @ 25° C Pe el S tr en gt h on S te el , N /2 5m m Pe el S tr en gt h on S te el , N /2 5m m PEEL STRENGTH ON STAINLESS STEEL Film Thickness: 51 micron LDPE/25 micron Versaflex PF F F F F F F F i i i i i i i www.avient.com Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2023-08/OnColor Lux Colorants for Glow-In-The-Dark Effects Product Bulletin.pdf
The portfolio includes color concentrates for the typical yellowish green, blue, blue-green, aqua and violet glow emissions.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
W H O W E A R E – V I S I O N , S T R AT E G Y, C U LT U R E 3 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 78% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of 2021年6月4日 87 89 87 86 83 81 76 88 85 83 82 81 80 78 78 78 76 72 71 69 50 18 A vi e n t K W R P P G R P M A V Y F U L G C P F M C H X L U N V R IF F E C L A S H F O E C E E M N B N R H U N G R A K R A S C L A L B Source: Peer data per Bloomberg market data as of 2021年6月4日 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi e n t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x S U M M A RY: W H Y I N V E S T I N AV I E N T ?